For research use only. Not for therapeutic Use.
Megazol(CAT: I012488) is a nitroimidazole derivative recognized for its potent antiparasitic and antiprotozoal activity. It has shown significant efficacy against Trypanosoma cruzi, the causative agent of Chagas disease, and other parasitic infections. Megazol functions by generating reactive oxygen species that damage the DNA and other cellular components of parasites, leading to their death. Due to its powerful action and potential therapeutic applications, Megazol is of great interest in pharmaceutical research, particularly in the development of new treatments for neglected tropical diseases. Researchers focused on parasitology, medicinal chemistry, and drug development use Megazol to explore novel antiparasitic therapies and to better understand its mechanism of action.
Catalog Number | I012488 |
CAS Number | 19622-55-0 |
Synonyms | 5-(1-methyl-5-nitroimidazol-2-yl)-1,3,4-thiadiazol-2-amine |
Molecular Formula | C6H6N6O2S |
Purity | ≥95% |
IUPAC Name | 5-(1-methyl-5-nitroimidazol-2-yl)-1,3,4-thiadiazol-2-amine |
InChI | InChI=1S/C6H6N6O2S/c1-11-3(12(13)14)2-8-4(11)5-9-10-6(7)15-5/h2H,1H3,(H2,7,10) |
InChIKey | VDZZTXBMKRQEPO-UHFFFAOYSA-N |
SMILES | CN1C(=CN=C1C2=NN=C(S2)N)[N+](=O)[O-] |